| Identification | |
| Name: | 1-Naphthalenemethanamine,a-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-,(aR)- |
| Synonyms: | AMG073;Cinacalcet; |
| CAS: | 226256-56-0 |
| Molecular Formula: | C22H22F3N |
| Molecular Weight: | 357.41 |
| InChI: | InChI=1/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 220.5 ºC |
| Boiling Point: | 440.9 ºC at 760mmHg |
| Density: | 1.154 g/cm3 |
| Refractive index: | 1.563 |
| Solubility: | In water, 9.2X10-2 mg/L at 25 deg C /Estimated/ |
| Appearance: | yellow oil |
| Flash Point: | 220.5 ºC |
| Usage: | Cinacalcet is the first calcimimetic drug approved by the United States Food and Drug Administration for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease |
| Safety Data | |
 |
|
